Altium Capital Management LP Arcutis Biotherapeutics, Inc. Transaction History

Altium Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.98 - $25.5 $3.82 Million - $6.5 Million	-255,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$19.28 - $27.1 $456,666 - $641,890	23,686 Added 10.24%	255,000 $5.77 Million
Q2 2021 Aug 13, 2021	BUY	$24.42 - $34.75 $2.87 Million - $4.08 Million	117,352 Added 102.97%	231,314 $6.31 Million
Q1 2021 May 06, 2021	BUY	$24.47 - $36.98 $1.25 Million - $1.89 Million	51,000 Added 81.0%	113,962 $3.3 Million
Q4 2020 Feb 16, 2021	BUY	$17.82 - $31.73 $1.12 Million - $2 Million	62,962 New	62,962 $1.77 Million

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.